The largest database of trusted experimental protocols

9 protocols using hepg2

1

Liver Cancer Cell Line Cultivation and Manipulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The human LIHC cell lines HepG-2 and Huh-7 were obtained from Procell Life Science&Technology Co., Ltd. (Wuhan, China). The human LIHC cell lines MHCC97-H and HCCLM-3 were obtained from Zhong Qiao Xin Zhou Biotechnology Co., Ltd. (Shanghai, China). The human normal liver cell line HL-7702 (L02) were obtained from Guan&Dao Biological Engineering Co., Ltd. (Shanghai, China). HepG-2, Huh-7, MHCC97-H and HCCLM-3 cells were cultured in DMEM (Cytiva, Utah, USA) with 10% FBS (Gibco, NY, USA) plus 1% penicillin and streptomycin (Sangon, Shanghai, China). L02 cell line was cultured in RIPA 1640 medium (Cytiva, Utah, USA) with 10% FBS plus 1% penicillin and streptomycin. All of the cells were cultured under humidified condition with 5% CO2 at 37 °C. The authentication of these cell lines was performed via comparisons with the STR database.
The lentivirus vectors LV–NC–shRNA, LV-CCDC115-shRNA and LV-CCDC115-OE were purchased from GenePharma (Shanghai, China). HepG-2 and HCCLM-3 cells were infected with lentivirus (MOI: HepG-2 cell = 80 pfu/cell; HCCLM-3 cell = 100 pfu/cell) with hexadimethrine bromide (5 μg/mL, GenePharma) for 72 h and puromycin (GenePharma) at the concentration of 2 μg/mL (HepG-2) or 2.5 μg/mL (HCCLM-3) was used to select for stably transfected cells.
+ Open protocol
+ Expand
2

Silencing Oncogenic Pathways in HepG2 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human hepatocellular carcinoma cell lines (HepG2) were purchased from the Institute of Biochemistry and Cell Biology of the Chinese Academy of Sciences (Shanghai, China). The cells were cultured in Dulbecco’s Modified Eagle Medium (DMEM, Gibco, NY, USA), supplemented with 10% fetal bovine serum (FBS, Gibco) as well as 100 U/ml penicillin and 100 μg/ml streptomycin (Invitrogen, CA, USA) and maintained at 37 °C with 5% CO2.
Small double-strand interference RNAs (siRNAs) for LASER (CCUCUUCUAAGCUCUUUAUTT), LSD1 (GAAGCTACATCTTACCTTA), EZH2 (GCTGAAGCCTCAATGTTTA), SREBP2 (CAAGGAGAGTCTATACTGT), CoREST(AAGAUUGUCCCGUUCUUGACU), LXRα (CTGCCCAGCAACAGTGTAA) and control scramble siRNA (UUCUCCGAACGUGUCACGUTT) were synthesized by GenePharma (Shanghai, China).
For RNAi assay, HepG2 cells were seeded at a density of 3.0 × 105 cells per well in a 6-well plate, when the density of cell reach to 70–90% the next day, transfection was performed. After the density of the cells reached to 70–90%, transfection was performed by incubating the siRNA with Lipofectamine RNAiMAX in Opti-MEM for 30 min at room temperature to allow siRNA-lipid complexes to form. Then, the mixed reagents were added to the target cells for a final concentration of 50 nM siRNA. After incubation with siRNA for 48 hrs, the cells were harvested for the experiments.
+ Open protocol
+ Expand
3

Transfection of Hepatoma Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
The human hepatoma cell lines HepG2, Huh7, and HepG2.2.15 were purchased from the Cell Bank of the Chinese Academy of Sciences (Shanghai, China). HepAD38 was provided by Professor Zhi Li, College of Life Sciences, Shaanxi Normal University.Ethics approval for the work was granted by the Ethics Committee of The Second Xiangya Hospital.Cells were maintained in Dulbecco’s modified Eagle’s medium (DMEM, HyClone, Shanghai, China) supplemented with 10% fetal bovine serum (FBS, Gibco, New York, USA) containing 100 U/mL penicillin and streptomycin (Cat. No. ST488, Beyotime, Beijing, China) at 37°C in a humidified atmosphere with 5% CO2. Cells were plated into 6-well plates at a density of 1×106 cells/well. After 24 hours, a concentration gradient of the HBV-miR-3 agomir or of the negative control (NC) RNA (artificially synthesized by GenePharma, Shanghai, China) was transfected into HepG2 cells and into HepAD38 cells. Transfection was performed using GP-siRNA-Mate Plus (GenePharma, Shanghai, China) according to the manufacturer’s instructions. The growth medium was changed after 8 hours. Transfected cells were harvested at 48 hours, and total cellular RNA and protein were isolated for RT-qPCR and Western blot analyses. All transfections were performed in triplicate. The blank group refers to cells that were not transfected with any RNA.
+ Open protocol
+ Expand
4

Modulation of circABCB10 and miR-670-3p in HCC

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human HCC cell lines HepG2, PLC, SK-Hep1, HCCLM3, Huh7 and Hep3B) and human LO2 normal liver cell lines were purchased from the Cell Center of Shanghai Institute of Biological Sciences. The human HCC cell line HepG2 was cultured in DMEM medium, and the remaining cells were cultured in RPMI 1640 medium.
si-circABCB10, si-HMG20A, miR-670-3p mimetic, miR-670-3p agomi (GenePharma, Shanghai, China) was transfected into cells using Lipofectamine 2000 (Invitrogen, Waltham, MA, USA). The sequence of si-circABCB10 was as follows: 5′-TGGTGAAATAAATATGCGCAA-3′. The human cDNA sequence of circABCB10 was cloned into the pcD-ciR vector to construct a circABCB10 overexpression plasmid and transfected with Lipofectamine 2000 (Invitrogen).
+ Open protocol
+ Expand
5

Modulating circFASN and miR-33a in Liver Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
Hep-G2 and Huh7 (human hepatocellular adenocarcinoma) cell lines were purchased from the Cell Bank of the Chinese Academy of Sciences (Shanghai, China). Hep-G2 and Huh7 cells were maintained in DMEM (Gibco, USA) supplemented with 10% FBS at 37 °C in a humidified atmosphere of 95% air with 5% CO2.
For circFASN overexpression and silencing, the circFASN plasmid and siRNA targeting the junction region of circFASN were purchased from Guangzhou Geneseed Biotech Co (Guangzhou, China). Hep-G2 and Huh7 cells were transfected with the overexpression plasmid or siRNA by using Lipo3000 Transfection Reagent (Invitrogen, USA).
For miR-33a overexpression and inhibition, Hep-G2 and Huh7 cells were transfected with 50 nM miRNA mimics (miR-33a) or 100 nM miRNA inhibitor (anti-miR-33a) (GenePharma, Shanghai, China) by using Lipo3000 Transfection Reagent (Invitrogen). Control groups were treated with equal concentrations of nontargeting mimic or inhibitor negative control sequences to control for nonspecific effects.
+ Open protocol
+ Expand
6

Silencing NPM1 in HepG2 Liver Cancer Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The human liver cancer cell line, HepG2, was obtained from the American Type Culture Collection (ATCC) and cultured in Gibco Dulbecco’s Modified Eagle Medium (DMEM) (Gibco Invitrogen Corporation, Australia) supplemented with 10% foetal bovine serum (FBS, Gibco Invitrogen Corporation, Australia). All the cells were maintained in a controlled humidified atmosphere containing 5% of carbon dioxide and 95% of air. Therefore, to determine whether silencing NPM1 affects the HepG2 cell chemotaxis and migration, three different specific small interfering RNAs (siRNAs) targeting NPM1 RNA and a negative control (NC) siRNA were synthesised by GenePharma (Shanghai, China) and used for in vitro transfection. Finally, the HepG2 cells were incubated for 48 h, and the protein expression was subsequently confirmed by Western blotting.
+ Open protocol
+ Expand
7

Liver Cell Line Culture and Transfection

Check if the same lab product or an alternative is used in the 5 most similar protocols
The human normal liver cell line (L-02) and liver cancer cell lines (Huh7, HepG2, Hep3B, SMMC-7721, and SK-Hep-1) were purchased from Procell (Wuhan, China). L-02 and SMMC-7721 cells were maintained in RPMI 1640 (#11875119, Thermo Fisher, USA) supplemented with 5% FBS (#12303C, Sigma-Aldrich, USA) and 1% penicillin/streptomycin (#SV30010, GE Healthcare, USA). The remaining cells were cultured in DMEM (#10313021, Thermo Fisher, USA) containing 10% FBS and 1% penicillin/streptomycin. Cells were all incubated in a humidified 5% CO2 incubator at 37°C.
HepG2 cells were transfected with miR-10b-5p mimics, mimics NC (GenePharma, China), oe-NC, or oe-SLC38A2 vector (HonorGene, China). SK-Hep-1 cells were transfected with miR-10b-5p inhibitors and inhibitor NC (GenePharma, China) using Lipofectamine 2000 (#11668019, Thermo Fisher, USA) according to the manufacturer’s guidelines. To induce apoptosis, SK-Hep-1 and HepG2 cells were treated with the apoptosis inducer staurosporine (STS, 5 μM, #S1421, Selleck, USA) for 12 h.
+ Open protocol
+ Expand
8

Human HCC Cell Culture Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Hep1, HepG2, Hep3B, Huh7, and SMMC7721 human HCC cells and L02 normal liver cells purchased from GenePharma Technology Co., Ltd were studied in our research. Cells were cultured in DMEM supplemented with 10% FBS and 1% penicillin/streptomycin in a humidified 5% CO2 incubator at 37°C.
+ Open protocol
+ Expand
9

Transfection of HCC cell lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
HCC cell lines (Huh7, SMMC-7721, HepG2, Hep3B, and BEL-7404) and immortalized normal liver cell line LO2 were purchased from the American Type Culture Collection (ATCC, Manassas, VA, USA). All cells were maintained with RPMI-1640 medium (Gibco, Grand Island, NY, USA) supplemented with 10% FBS (Thermo Fisher Scientific, Inc., Waltham, MA, USA), and fostered in a humidified incubator containing 5% CO2. When growing to 70–80% confluence, SMMC7721 and HepG2 cells were transfected with miR-137 mimics (miR-137), miR-137 antagomir (anti-miR-137), respective negative controls (miR-NC, anti-miR-NC), or miR-137 + Lv-DNMT3a (GenePharma Shanghai, China) with Lipofectamine 3000 reagent (Invitrogen, Carlsbad, CA, USA). The transfected cells were harvested for further analyses.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!